← Eichor
Study identifier: NCT06892353 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

AI-Powered DIY Screening System for Diabetic Retinopathy

Condition: Diabetic Retinopathy  ·  Sponsor: The Hong Kong Polytechnic University

PhaseNA
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

A pragmatic trial will be conducted in two representative clinics in each of the three types of targeted settings. It will be run for 3 months in each clinic to complete data collection of up to 100 patients in SPGC and Optometry Clinics, 200 at GPGC and 200 in GOPC in total. All the subjects will conduct a DIY screening, physician consultation, survey with questionnaires and a phone interview three months after their baseline assessment. This study will assess automated screening in terms of success rate of the DIY system without active assistant help, accuracy, screening rate and detection rate, adherence to referral and experience of participants, as well as cost-effectiveness in real-world settings.

This description comes directly from the study's public registry record.

Talk to the study team

Mingguang He  ·  85234002795  ·  mingguang.he@polyu.edu.hk

Yanxian Chen  ·  85227666111  ·  yan-xian.chen@polyu.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

SPGC and Optometry ClinicsHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06892353